| Financial Year |
March 31 2023 |
| Monetary Funds |
4,742,152,535.72 |
| Held-for-trading Financial Assets |
4,773,752,385.44 |
| Notes Receivable |
7,393,280.66 |
| Accounts Receivable |
2,747,703,569.02 |
| Advances to Suppliers |
2,448,449,261.12 |
| Other Receivables |
410,644,964.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,022,057,102.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
160,336,408.60 |
| Other Current Assets |
363,242,447.79 |
| Total Current Assets |
20,822,400,852.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
154,224,702.69 |
| Long-term Equity Investment |
1,789,892,548.23 |
| Investment Properties |
743,401,364.81 |
| Fixed Assetes |
1,241,821,901.56 |
| Under-construction Projects |
5,127,400.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
625,286,288.78 |
| R&D expenses |
3,884,966.64 |
| Goodwill |
166,056,398.85 |
| Long-Term Deferred and Prepaid Expenses |
70,036,693.68 |
| Deferred Income Tax Assets |
505,557,606.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,512,636,073.76 |
| Total Assets |
26,335,036,926.16 |
| Short-Term Loans |
9,175,439,220.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
431,351,643.97 |
| Accounts Payable |
2,413,682,748.20 |
| Accounts Received In Advance |
55,067,489.89 |
| Employee Compensation Payable |
128,229,903.86 |
| Taxes Payable |
156,316,781.72 |
| Interest Payable |
-- |
| Dividend Payable |
2,457,696.54 |
| Other payables |
1,599,122,578.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
272,605,547.13 |
| Other Current Liabilities |
288,868,866.78 |
| Sub-Total of Current Liabilities |
17,176,167,088.10 |
| Long-term Loans |
2,181,647,502.38 |
| Bonds Payable |
189,283,068.47 |
| Long-Term Accounts Payable |
76,072,625.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,632,707.05 |
| Deferred Income Tax Liabilities |
418,666,022.90 |
| Other Non-Current Liabilities |
91,522,500.51 |
| Sub-Total of Non-Current Liabilities |
3,160,688,262.02 |
| Total Liabilities |
20,336,855,350.12 |
| Paid-In Capital(Or Share Stock) |
2,242,433,192.00 |
| Capital Surplus |
701,543,666.22 |
| Surplus Reserve |
517,209,719.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,645,534,663.32 |
| Minority Stockholder's Interest |
881,141,129.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,117,040,446.64 |
| Owner's Equity（Stockholder's Equity） |
5,998,181,576.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,335,036,926.16 |
